Clinical Trial Update: Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) [Phase 1, Phase 2]

View source ↗

Summary

This document describes a Phase 1/2 trial evaluating the combination of venetoclax with blinatumomab in adults with relapsed or refractory B-cell precursor acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Precursor Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)
• Venetoclax (venetoclax)

Snippet

Sponsor: Goethe University | Conditions: ALL, Recurrent, Adult | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING